annexin v-fitc and pi reagents in binding buffer using the annexin v-fitc/pi cell apoptosis detection kit (Beyotime)
Structured Review
Annexin V Fitc And Pi Reagents In Binding Buffer Using The Annexin V Fitc/Pi Cell Apoptosis Detection Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/binding+buffer+cell+apoptosis+kit/annexin+v+fitc+and+pi+reagents+in+binding+buffer+using+the+annexin+v+fitc+pi+cell+apoptosis+detection+kit/pmc04933872-32-32-48
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Upregulation of MicroRNA-214 Contributes to the Development of Vascular Remodeling in Hypoxia-induced Pulmonary Hypertension Via Targeting CCNL2 Article Snippet: After 48 h, the cells treated under various conditions were incubated in 1.5% H 2 O 2 for 24 h. The cells were then starved in medium containing 0.1% FBS; stained with Annexin V-FITC and PI reagents in binding buffer using the Binding Assay:Article Title: miR-221 regulates proliferation and apoptosis of ovarian cancer cells by targeting BMF. Article Snippet: .. Cells were re-suspended in 100 μl binding buffer (part of the apoptosis detection kit), then cells were incubated with a Incubation:Article Title: miR-221 regulates proliferation and apoptosis of ovarian cancer cells by targeting BMF. Article Snippet: .. Cells were re-suspended in 100 μl binding buffer (part of the apoptosis detection kit), then cells were incubated with a Modification:Article Title: Long-Circulating and Targeted Liposomes Co-loading Cisplatin and Mifamurtide: Formulation and Delivery in Osteosarcoma Cells. Article Snippet: Osteosarcoma (OS) is one of the most common primary bone sarcoma with high malignant degree and poor prognosis, for which there is an urgent need to develop novel therapeutic approaches.. Recent research has revealed that mifamurtide significantly improved the outcome of OS patients when combined with adjuvant chemotherapy drugs including cisplatin (DDP).. The present study aimed to construct a drug delivery system co-loading DDP and mifamurtide. Double Staining:Article Title: Long-Circulating and Targeted Liposomes Co-loading Cisplatin and Mifamurtide: Formulation and Delivery in Osteosarcoma Cells. Article Snippet: Osteosarcoma (OS) is one of the most common primary bone sarcoma with high malignant degree and poor prognosis, for which there is an urgent need to develop novel therapeutic approaches.. Recent research has revealed that mifamurtide significantly improved the outcome of OS patients when combined with adjuvant chemotherapy drugs including cisplatin (DDP).. The present study aimed to construct a drug delivery system co-loading DDP and mifamurtide. |
